These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 33359069)
1. Negative correlation of urinary miR-199a-3p level with ameliorating effects of sarpogrelate and cilostazol in hypertensive diabetic nephropathy. Kim SK; Kim G; Choi BH; Ryu D; Ku SK; Kwak MK Biochem Pharmacol; 2021 Feb; 184():114391. PubMed ID: 33359069 [TBL] [Abstract][Full Text] [Related]
2. p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO. Yang R; Xu X; Li H; Chen J; Xiang X; Dong Z; Zhang D Sci Rep; 2017 Feb; 7():43409. PubMed ID: 28240316 [TBL] [Abstract][Full Text] [Related]
3. miR-199a-3p promotes cardiomyocyte proliferation by inhibiting Cd151 expression. Tao Y; Zhang H; Huang S; Pei L; Feng M; Zhao X; Ouyang Z; Yao S; Jiang R; Wei K Biochem Biophys Res Commun; 2019 Aug; 516(1):28-36. PubMed ID: 31186138 [TBL] [Abstract][Full Text] [Related]
4. Renal microRNA-144-3p is associated with transforming growth factor-β1-induced oxidative stress and fibrosis by suppressing the NRF2 pathway in hypertensive diabetic kidney disease. Kim SK; Bae GS; Bae T; Ku SK; Choi BH; Kwak MK Free Radic Biol Med; 2024 Nov; 225():546-559. PubMed ID: 39423929 [TBL] [Abstract][Full Text] [Related]
5. Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice. Kim DH; Choi BH; Ku SK; Park JH; Oh E; Kwak MK PLoS One; 2016; 11(4):e0153965. PubMed ID: 27097221 [TBL] [Abstract][Full Text] [Related]
6. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-β1 pathway. Zhang Y Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 33729484 [TBL] [Abstract][Full Text] [Related]
7. Telmisartan Attenuates the Growth of Epithelium-like Cells and Glomerular Injury in Spontaneously Hypertensive Rats. Zhang Z; Wang FZ; Li ZX; Song XR Curr Med Sci; 2021 Jun; 41(3):498-504. PubMed ID: 34129200 [TBL] [Abstract][Full Text] [Related]
8. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151. Kim JH; Badawi M; Park JK; Jiang J; Mo X; Roberts LR; Schmittgen TD Int J Oncol; 2016 Nov; 49(5):2037-2045. PubMed ID: 27599545 [TBL] [Abstract][Full Text] [Related]
9. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy. Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566 [TBL] [Abstract][Full Text] [Related]
10. The activation of GPER inhibits cells proliferation, invasion and EMT of triple-negative breast cancer via CD151/miR-199a-3p bio-axis. Huang R; Li J; Pan F; Zhang B; Yao Y Am J Transl Res; 2020; 12(1):32-44. PubMed ID: 32051735 [No Abstract] [Full Text] [Related]
11. miR-199a-3p may be an early warning marker for acute rejection after liver transplantation in rats. Mo J; Chen Y; Cheng Y; Hua W; He W; Chen L Cytokine; 2021 Dec; 148():155689. PubMed ID: 34507247 [TBL] [Abstract][Full Text] [Related]
12. Linagliptin and telmisartan induced effects on renal and urinary exosomal miRNA expression in rats with 5/6 nephrectomy. Delić D; Wiech F; Urquhart R; Gabrielyan O; Rieber K; Rolser M; Tsuprykov O; Hasan AA; Krämer BK; Baum P; Köhler A; Gantner F; Mark M; Hocher B; Klein T Sci Rep; 2020 Feb; 10(1):3373. PubMed ID: 32099009 [TBL] [Abstract][Full Text] [Related]
13. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy. Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064 [TBL] [Abstract][Full Text] [Related]
14. Involvement of miR-27a-3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress. Wu L; Wang Q; Guo F; Ma X; Wang J; Zhao Y; Yan Y; Qin G J Cell Physiol; 2021 Feb; 236(2):1454-1468. PubMed ID: 32691413 [TBL] [Abstract][Full Text] [Related]
15. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy. Wu J; Liu J; Ding Y; Zhu M; Lu K; Zhou J; Xie X; Xu Y; Shen X; Chen Y; Shao X; Zhu C Biochem Biophys Res Commun; 2018 Sep; 503(2):977-983. PubMed ID: 29932921 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of urine exosomes derived from rats with diabetic kidney disease. Mishra DD; Sahoo B; Maurya PK; Sharma R; Varughese S; Prasad N; Tiwari S Front Endocrinol (Lausanne); 2023; 14():1157194. PubMed ID: 37251672 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic activity of sarpogrelate and dopamine D Fouad Shalaby MA; Abd El Latif HA; El Yamani M; Galal MA; Kamal S; Sindi I; Masaood R BMC Pharmacol Toxicol; 2021 Oct; 22(1):64. PubMed ID: 34702339 [TBL] [Abstract][Full Text] [Related]
18. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517 [TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits extracellular matrix accumulation, inflammation and proliferation of mesangial cells in diabetic nephropathy by regulating H19/miR-143-3p/TGF-β1 axis. Xu J; Xiang P; Liu L; Sun J; Ye S J Pharm Pharmacol; 2020 Aug; 72(8):1101-1109. PubMed ID: 32391614 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor β1 (TGF-β1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cells. Castro NE; Kato M; Park JT; Natarajan R J Biol Chem; 2014 Oct; 289(42):29001-13. PubMed ID: 25204661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]